Jing Wang

1PUBLICATIONS

7CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Apr 09, 2025

Preclinical development of ozuriftamab vedotin (BA3021), a novel ROR2-specific conditionally active biologic antibody-drug conjugate.

Hwai Wen Chang, Gerhard Frey, Jing Wang

Pageof 1

Frequent Collaborators

1 joint publications

Hwai Wen Chang

1 joint publications

Gerhard Frey

1 joint publications

Haizhen Liu

1 joint publications

Charles Xing

1 joint publications

Jian Chen

1 joint publications

William J Boyle

1 joint publications

Jay M Short

Frequent Collaborators

1 joint publications

Hwai Wen Chang

1 joint publications

Gerhard Frey

1 joint publications

Haizhen Liu

1 joint publications

Charles Xing